Earnings4506Sumitomo Pharma Co.,Ltd.
Sumitomo Pharma Reports Q1 Revenue of 130 billion, Up 20%
TOKYO, Jul 31 (Pulse News Wire) – Sumitomo Pharma Co., Ltd. (4506.T) reported consolidated results for Q1 FY2027 (ending March 2027).
Revenue was ¥130 billion (+19.9% YoY). operating profit was ¥18,134 million (-11.0%).
Net profit attributable to shareholders was ¥16,997 million (+51.7%). The full-year forecast for the current fiscal year is revenue of ¥540 billion (+19.1%).
Financial results — FY2027/3 (consolidated)
| Metric | Current | YoY |
|---|---|---|
| Revenue | ¥129,495M | +19.9% |
| Operating profit | ¥18,134M | -11.0% |
| Net profit | ¥16,997M | +51.7% |
Next period forecast
Revenue
¥540,000M
+19.1%Op. profit
¥91,000M
-14.1%Net profit
¥77,000M
-27.9%Source: TDNet filing · Figures in millions of yen
End of article